Skip to content
Catalyst

PapersPMID:32386521

The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.

Journal of ovarian research2020The record ↗

findings
4
compound
1
endpoints
4
PMID:32386521
  1. Finding, insufficient evidencelowersC-reactive protein concentration
  2. Finding, insufficient evidencelowersInterleukin-6 concentration
  3. Finding, insufficient evidenceraisesSuperoxide dismutase activity
  4. Finding, insufficient evidencelowersMalondialdehyde (circulating)
Study, every finding
animal · not in humans
Dose studied, every finding
0.5 g/kg, intraperitoneal, twice on the morning after the last DHEA injection
Population, every finding
Female Sprague-Dawley rats, DHEA-induced PCOS model, 0.5 g/kg glutamine dose
  • “All the detected inflammation factors [C-reactive protein, interleukin (IL)-6, IL-18, tumor necrosis factor] showed significantly higher in all the PCOS groups compared to the control group (P < 0.01), and were significantly decreased with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
  • “Concentrations of superoxide dismutase were significantly lower in all the PCOS groups (P < 0.01) compared to the control group, and increased significantly with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
  • “Serum concentrations of malondialdehyde, nitric oxide synthase and nitric oxide were significantly higher in PCOS group (P < 0.01) compared with the control group, and significantly decreased to the comparative levels of control group with supplementation of 0.5 g/kg glutamine (P < 0.01).”

Study record

Design
animal study, in vivo
Species
animal
Population
Female Sprague-Dawley rats, DHEA-induced PCOS model, four groups: control, PCOS, PCOS + 0.5 g/kg glutamine, PCOS + 1.0 g/kg glutamine (n=10/group)
Participants
40
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
9